Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 8.

Journal Article

Braun, M., Gluz, O., Nitz, U., Christgen, M., Kuemmel, S., Schumacher, C., Potenberg, J., Kraemer, S., Kleine-Tebbe, A., Augustin, D., Aktas, B., Forstbauer, H., Tio, J., Liedtke, C., Kates, R. E., Wuerstlein, R., Kreipe, H. -H. and Harbecks, N. (2016). Final analysis of WSG-ADAPT HER2+/HR+ phase-II-trial - efficacy, safety and predictive markers for 12-weeks of neoadjuvant T-DM1 with or without endocrine therapy versus Trastuzumab plus endocrine therapy in HER2-positive hormone-receptor-positive early breast cancer. Oncol. Res. Treat., 39. S. 2 - 3. BASEL: KARGER. ISSN 2296-5262

Goebell, P., Salem, J., Struck, J. P., Stahl, L., Oelke, M., Sommerkamp, H. J., Schwaibold, R., Braun, M., Berges, R. and Schoeneberger, M. (2016). Generation Y - problem or solution in daily clinical practice (vol 55, pg 1047, 2016). Urologe, 55 (11). S. 1486 - 1487. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Goebell, P., Salem, J., Strunk, J., Stahl, L., Oelke, M., Sommerkamp, H. J., Schwaibold, R., Braun, M., Berges, R. and Schoeneberger, M. (2016). Generation Y Problem or Solution in daily Clinical Practice? Urologe, 55 (8). S. 1047 - 1050. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Harbeck, N., Gluz, O., Christgen, M., Braun, M., Kuemmel, S., Schumacher, C., Potenberg, J., Kraemer, S., Kleine-Tebbe, A., Augustin, D., Aktas, B., Forstbauer, H., Tio, J., Liedtke, C., Kates, R. E., Wuerstlein, R., de Haas, S. L., Kiermaier, A., Kreipe, H. H. and Nitz, U. (2016). Final analysis of WSG-ADAPT HER2+/HR+ phase II trial: Efficacy, safety, and predictive markers for 12-weeks of neoadjuvant TDM1 with or without endocrine therapy versus trastuzumab plus endocrine therapy in HER2-positive hormone-receptor positive early breast cancer. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Harbeck, N., Nitz, U. A., Matthias, C., Kates, R., Braun, M., Kummel, S., Schumacher, C., Potenberg, J., Kraemer, S., Kleine-Tebbe, A., Augustin, D., Aktas, B., Forstbauer, H., Tio, J., Liedtke, C., Grischke, E-M, de Haas, S. L., Deurloo, R., Schumacher, J., Wuerstlein, R., Kreipe, H. H. and Gluz, O. (2017). The role of immune and apoptosis markers for prediction of pCR in the WSG-ADAPT HER2+/HR+ phase II trial evaluating 12-weeks of neoadjuvant TDM1 +/- endocrine therapy (ET) versus T + ET in HER2-positive hormone-receptor-positive early breast cancer (EBC). Cancer Res., 77. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Nitz, U. A., Gluz, O., Christgen, M., Grischke, E. -M, Augustin, D., Kuemmel, S., Braun, M., Potenberg, J., Kohls, A., Krauss, K., Stefek, A., Schumacher, C., Forstbauer, H., Reimer, T., Fischer, H., Liedtke, C., Wuerstlein, R., Schumacher, J., Kates, R., Kreipe, H. and Harbeck, N. (2017). De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab +/- weekly paclitaxel. Ann. Oncol., 28 (11). S. 2768 - 2773. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Struck, J. P., Stahl, L., Braun, M., Homberg, R., Schoenberger, M., Westphal, J. and Salem, J. (2019). The working time load of specialists and senior physicians in German urology-a critical assessment. Urologe, 58 (8). S. 918 - 924. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Westphal, J., Struck, J., Homberg, R., Salem, J., Stahl, L. and Braun, M. (2019). Workload, job satisfaction, Work Time Act-what is urology doing? Urologe, 58 (8). S. 881 - 885. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

This list was generated on Fri Jan 22 04:43:28 2021 CET.